Abstract
Many epidemiologic studies have demonstrated a clear association between viral bronchiolitis early in life and subsequent development of persistent wheezing. Despite that a number of studies have been conducted to reduce post-bronchiolitis wheeze, we do not have consistent evidence of an effective strategy. Two different therapeutic approaches have been evaluated: a) anti-inflammatory and/or immunomodulatory agents; and b) specific anti-viral agents. Corticosteroids have been evaluated by different routes and doses in children with RSV bronchiolitis with disappointing results. Recent data, however, suggest a potential benefit of corticosteroids in reducing the long-term wheezing associated with rhinovirus bronchiolitis. Studies evaluating the anti leukotriene receptor antagonist – montelukast — have showed inconsistent results. Finally, studies in premature infants using agents that specifically target RSV, more specifically anti-RSV antibodies (palivizumab), have provided encouraging results indicating the need to design larger studies in broader patient populations.
Keywords: RSV, asthma, steroids, monoclonal antibodies, montelukast, Bronchiolitis, wheeze, anti-inflammatory, immunomodulatory, anti-viral agents, Corticosteroids
Current Respiratory Medicine Reviews
Title: Interventions to Prevent Long-Term Consequences of Bronchiolitis
Volume: 7 Issue: 3
Author(s): Asuncion Mejias and Octavio Ramilo
Affiliation:
Keywords: RSV, asthma, steroids, monoclonal antibodies, montelukast, Bronchiolitis, wheeze, anti-inflammatory, immunomodulatory, anti-viral agents, Corticosteroids
Abstract: Many epidemiologic studies have demonstrated a clear association between viral bronchiolitis early in life and subsequent development of persistent wheezing. Despite that a number of studies have been conducted to reduce post-bronchiolitis wheeze, we do not have consistent evidence of an effective strategy. Two different therapeutic approaches have been evaluated: a) anti-inflammatory and/or immunomodulatory agents; and b) specific anti-viral agents. Corticosteroids have been evaluated by different routes and doses in children with RSV bronchiolitis with disappointing results. Recent data, however, suggest a potential benefit of corticosteroids in reducing the long-term wheezing associated with rhinovirus bronchiolitis. Studies evaluating the anti leukotriene receptor antagonist – montelukast — have showed inconsistent results. Finally, studies in premature infants using agents that specifically target RSV, more specifically anti-RSV antibodies (palivizumab), have provided encouraging results indicating the need to design larger studies in broader patient populations.
Export Options
About this article
Cite this article as:
Mejias Asuncion and Ramilo Octavio, Interventions to Prevent Long-Term Consequences of Bronchiolitis, Current Respiratory Medicine Reviews 2011; 7 (3) . https://dx.doi.org/10.2174/157339811795589496
DOI https://dx.doi.org/10.2174/157339811795589496 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Does HbA1cc Play a Role in the Development of Cardiovascular Diseases?
Current Pharmaceutical Design Actions of Relaxin on Non-Reproductive Tissues
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The IGF-I Signaling Pathway
Current Pharmaceutical Design Episcleritis and Scleritis in Rheumatic Disease
Current Rheumatology Reviews Endothelin-1 Actions on Vascular Smooth Muscle Cell Functions As a Target for the Prevention of Atherosclerosis
Current Vascular Pharmacology Low Levels of High Density Lipoprotein Increase the Severity of Cerebral White Matter Changes:Implications for Prevention and Treatment of Cerebrovascular Diseases
Current Alzheimer Research A Systematic Review of Lifestyle Modification and Glucose Intolerance in the Prevention of Type 2 Diabetes
Current Diabetes Reviews Editorial: Time for Earlier and More Intensive Preventive Therapy
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Clinical Pharmacology Flavonoid Rich Fraction of Dioscorea bulbifera Linn. (Yam) Enhances Mitochondrial Enzymes and Antioxidant Status, Thereby Protects Heart from Isoproterenol Induced Myocardial Infarction
Current Pharmaceutical Biotechnology Ghrelin in Obesity, Physiological and Pharmacological Considerations
Mini-Reviews in Medicinal Chemistry The Role of Inflammatory Response in Stroke Associated Programmed Cell Death
Current Neuropharmacology Therapeutic Use of Snake Venom Components: A Voyage from Ancient to Modern India
Mini-Reviews in Organic Chemistry Vascular Toxicity of Chemotherapeutic Agents
Current Vascular Pharmacology Inspired Nitric Oxide and Modulation of Oxidative Stress During Cardiac Surgery
Current Drug Safety Chlorella vulgaris: A Multifunctional Dietary Supplement with Diverse Medicinal Properties
Current Pharmaceutical Design Role of Polyunsaturated Fatty Acids and Fatty Acid Binding Protein in the Pathogenesis of Schizophrenia
Current Pharmaceutical Design Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
CNS & Neurological Disorders - Drug Targets The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Current Drug Targets